2. Search Result
Search Result
No matches for "

64776

" within the MedChemExpress (MCE) catalog. Here are the results you might be looking for.

31

Inhibitors & Agonists

1

Peptides

1

Isotope-Labeled Compounds

4

Antibodies

16

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-11018
    Risperidone
    5+ Cited Publications

    R 64 766

    		 5-HT Receptor Dopamine Receptor P-glycoprotein Neurological Disease
    Risperidone is a serotonin 5-HT2 receptor blocker, P-Glycoprotein inhibitor and potent dopamine D2 receptor antagonist, with Kis of 4.8, 5.9 nM for 5-HT2A and dopamine D2 receptor, respectively.
    Risperidone
  • HY-B1085
    Cinoxacin
    1 Publications Verification

    Compound 64716

    		 Bacterial Antibiotic DNA/RNA Synthesis Infection
    Cinoxacin (Compound 64716), a synthetic antimicrobial related to the quinolone class of orally active antibacterial agent. Cinoxacin has antibacterial activity against many gram-negative aerobic bacteria and inhibits bacterial DNA synthesis. Cinoxacin can be used for the research of urinary tract infections and bacterial prostatitis .
    Cinoxacin
  • HY-100685
    MS-444
    2 Publications Verification

    BE-34776

    		 HuR Apoptosis COX Neurological Disease Cancer
    MS-444 (BE-34776) is a HuR (ELAVL1) inhibitor that blocks the cytoplasmic translocation of HuR and inhibits its dimerization. MS-444 reduces cytoplasmic HuR levels by preventing the binding of HuR to ARE-mRNA, without altering the total expression of HuR. MS-444 induces apoptosis, inhibits cell growth, angiogenesis and invasion, and also regulates immune function and microbiota. MS-444 effectively alters the number, size and invasiveness of tumors in various cancer models. MS-444 is tolerable to intraperitoneal injection in vivo and can be applied to research related to colorectal cancer, familial adenomatous polyposis, colitis-associated cancer and glioblastoma .
    MS-444
  • HY-107986
    GNE-6776
    Maximum Cited Publications
    7 Publications Verification

    		 Deubiquitinase Cancer
    GNE-6776 is a selective and orally bioavailable USP7 inhibitor .
    GNE-6776
  • HY-103307
    FPL64176

    		Calcium Channel Cardiovascular Disease
    FPL64176, a nondihydropyridine compound, is a potent agonist of L-type Ca 2+ channels with an EC50 value of 16 nM .
    FPL64176
  • HY-116568
    Prothioconazole

    JAU-6476

    		 Environmental Pollutants Fungal Cytochrome P450 Infection
    Prothioconazole is a triazolinthione fungicide. Prothioconazole is a CYP51 inhibitor .
    Prothioconazole
  • HY-R02114
    hsa-miR-6776-3p mimic

    		MicroRNA Cancer
    hsa-miR-6776-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-miR-6776-3p mimic
    hsa-miR-6776-3p mimic
  • HY-11018B
    Risperidone mesylate

    R 64 766 mesylate

    		 5-HT Receptor Dopamine Receptor P-glycoprotein Neurological Disease
    Risperidone mesylate(R 64 766 mesylate) is a serotonin 5-HT2 receptor blocker, P-Glycoprotein inhibitor and potent dopamine D2 receptor antagonist, with Kis of 4.8, 5.9 nM for 5-HT2A and dopamine D2 receptor, respectively.
    Risperidone mesylate
  • HY-11018A
    Risperidone hydrochloride

    R 64 766 hydrochloride

    		 5-HT Receptor Dopamine Receptor P-glycoprotein Neurological Disease
    Risperidone hydrochloride (R 64 766 hydrochloride) 5-HT2 receptor blocker, P-Glycoprotein inhibitor and potent dopamine D2 receptor antagonist, with Kis of 4.8, 5.9 nM for 5-HT2A and dopamine D2 receptor, respectively.
    Risperidone hydrochloride
  • HY-B1085R
    Cinoxacin (Standard)

    Compound 64716 (Standard)

    		 Reference Standards Bacterial Antibiotic DNA/RNA Synthesis Infection
    Cinoxacin (Standard) is the analytical standard of Cinoxacin. This product is intended for research and analytical applications. Cinoxacin (Compound 64716), a synthetic antimicrobial related to the quinolone class of orally active antibacterial agent. Cinoxacin has antibacterial activity against many gram-negative aerobic bacteria and inhibits bacterial DNA synthesis. Cinoxacin can be used for the research of urinary tract infections and bacterial prostatitis .
    Cinoxacin (Standard)
  • HY-103307R
    FPL64176 (Standard)

    		Reference Standards Calcium Channel Cardiovascular Disease
    FPL64176 (Standard) is the analytical standard of FPL64176. This product is intended for research and analytical applications. FPL64176, a nondihydropyridine compound, is a potent agonist of L-type Ca2+ channels with an EC50 value of 16 nM .
    FPL64176 (Standard)
  • HY-P10246
    Hemoglobin (64-76)

    		MHC Inflammation/Immunology
    Hemoglobin 64-76 is a T cell inducing determinant, that binds to two different MHC class II molecules in distinct registers and lengths .
    Hemoglobin (64-76)
  • HY-116568R
    Prothioconazole (Standard)

    JAU-6476 (Standard)

    		 Fungal Cytochrome P450 Reference Standards Infection
    Prothioconazole (Standard) is the analytical standard of Prothioconazole. This product is intended for research and analytical applications. Prothioconazole is a triazolinthione fungicide. Prothioconazole is a CYP51 inhibitor .
    Prothioconazole (Standard)
  • HY-R02115
    hsa-miR-6776-5p mimic

    		MicroRNA Cancer
    hsa-miR-6776-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-miR-6776-5p mimic
    hsa-miR-6776-5p mimic
  • HY-R01404
    hsa-miR-4776-3p mimic

    		MicroRNA Cancer
    hsa-miR-4776-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-miR-4776-3p mimic
    hsa-miR-4776-3p mimic
  • HY-R01405A
    hsa-miR-4776-5p agomir

    		MicroRNA Cancer
    hsa-miR-4776-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-4776-5p agomir
    hsa-miR-4776-5p agomir
  • HY-R01405
    hsa-miR-4776-5p mimic

    		MicroRNA Cancer
    hsa-miR-4776-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
    hsa-miR-4776-5p mimic
    hsa-miR-4776-5p mimic
  • HY-11018R
    Risperidone (Standard)

    R 64 766 (Standard)

    		 Dopamine Receptor 5-HT Receptor P-glycoprotein Reference Standards Neurological Disease
    Risperidone (Standard) is the analytical standard of Risperidone. This product is intended for research and analytical applications. Risperidone is a serotonin 5-HT2 receptor blocker, P-Glycoprotein inhibitor and potent dopamine D2 receptor antagonist, with Kis of 4.8, 5.9 nM for 5-HT2A and dopamine D2 receptor, respectively.
    Risperidone (Standard)
  • HY-116568S
    Prothioconazole-d4

    JAU-6476-d4

    		 Isotope-Labeled Compounds Fungal Cytochrome P450 Infection
    Prothioconazole-d4 (JAU-6476-d4) is the deuterium labeled Prothioconazole (HY-116568). Prothioconazole is a triazolinthione fungicide. Prothioconazole is a CYP51 inhibitor .
    Prothioconazole-d4
  • HY-107986R
    GNE-6776 (Standard)

    		Reference Standards Deubiquitinase Cancer
    GNE-6776 (Standard) is the analytical standard of GNE-6776 (HY-107986). This product is intended for research and analytical applications. GNE-6776 is a selective and orally bioavailable USP7 inhibitor .
    GNE-6776 (Standard)
  • HY-RI02114A
    hsa-miR-6776-3p antagomir

    		MicroRNA Cancer
    hsa-miR-6776-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-6776-3p antagomir
    hsa-miR-6776-3p antagomir
  • HY-RI01405A
    hsa-miR-4776-5p antagomir

    		MicroRNA Cancer
    hsa-miR-4776-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-4776-5p antagomir
    hsa-miR-4776-5p antagomir
  • HY-RI01404
    hsa-miR-4776-3p inhibitor

    		MicroRNA Cancer
    hsa-miR-4776-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-4776-3p inhibitor
    hsa-miR-4776-3p inhibitor
  • HY-RI02114
    hsa-miR-6776-3p inhibitor

    		MicroRNA Cancer
    hsa-miR-6776-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-6776-3p inhibitor
    hsa-miR-6776-3p inhibitor
  • HY-RI01405
    hsa-miR-4776-5p inhibitor

    		MicroRNA Cancer
    hsa-miR-4776-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-4776-5p inhibitor
    hsa-miR-4776-5p inhibitor
  • HY-R02115A
    hsa-miR-6776-5p agomir

    		MicroRNA Cancer
    hsa-miR-6776-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-6776-5p agomir
    hsa-miR-6776-5p agomir
  • HY-RI02115
    hsa-miR-6776-5p inhibitor

    		MicroRNA Cancer
    hsa-miR-6776-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
    hsa-miR-6776-5p inhibitor
    hsa-miR-6776-5p inhibitor
  • HY-R01404A
    hsa-miR-4776-3p agomir

    		MicroRNA Cancer
    hsa-miR-4776-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-4776-3p agomir
    hsa-miR-4776-3p agomir
  • HY-R02114A
    hsa-miR-6776-3p agomir

    		MicroRNA Cancer
    hsa-miR-6776-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-6776-3p agomir
    hsa-miR-6776-3p agomir
  • HY-RI02115A
    hsa-miR-6776-5p antagomir

    		MicroRNA Cancer
    hsa-miR-6776-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-6776-5p antagomir
    hsa-miR-6776-5p antagomir
  • HY-RI01404A
    hsa-miR-4776-3p antagomir

    		MicroRNA Cancer
    hsa-miR-4776-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
    hsa-miR-4776-3p antagomir
    hsa-miR-4776-3p antagomir

Inquiry Online

Submit your filled information, we will contact you soon.

Salutation: * Country or Region:
* Applicant Name: * Organization Name:
* Department:    
* Email Address: * Product Name:
Cat. No.: * Requested quantity:
* Phone Number:    
Remarks:

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: